A detailed history of Valued Wealth Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Valued Wealth Advisors LLC holds 301 shares of NVO stock, worth $32,511. This represents 0.02% of its overall portfolio holdings.

Number of Shares
301
Previous 301 -0.0%
Holding current value
$32,511
Previous $43 Million 16.58%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $3,165 - $4,213
31 Added 11.48%
301 $38.9 Million
Q4 2023

Jan 05, 2024

BUY
$87.78 - $105.45 $23,700 - $28,471
270 New
270 $24.6 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Valued Wealth Advisors LLC Portfolio

Follow Valued Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valued Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valued Wealth Advisors LLC with notifications on news.